Health Economics & Outcomes Research (HEOR) careers focus on analyzing the economic impact, value, and outcomes of healthcare interventions, treatments, and policies. Professionals in HEOR use data to inform healthcare decision-making, improve patient outcomes, and optimize resource allocation. These careers are vital in pharmaceutical companies, healthcare consultancies, and government agencies, bridging the gap between clinical effectiveness and cost-effectiveness in medicine and healthcare delivery.
Health Economics & Outcomes Research (HEOR) careers focus on analyzing the economic impact, value, and outcomes of healthcare interventions, treatments, and policies. Professionals in HEOR use data to inform healthcare decision-making, improve patient outcomes, and optimize resource allocation. These careers are vital in pharmaceutical companies, healthcare consultancies, and government agencies, bridging the gap between clinical effectiveness and cost-effectiveness in medicine and healthcare delivery.
What is Health Economics & Outcomes Research (HEOR)?
HEOR studies the value of healthcare interventions by analyzing costs and patient outcomes to inform decisions by payers, providers, and policymakers.
What types of careers exist in HEOR?
Roles include health economist, outcomes researcher, pharmacoeconomist, statistician/analyst, real‑world evidence specialist, and market access/payor-focused positions in pharma, CROs, academia, and health systems.
What education paths are common for HEOR careers?
Most professionals hold a master's or PhD in health economics, economics, public health, biostatistics, or related fields, with training in economic evaluation and programming skills (R, SAS, Stata).
What skills are valuable in HEOR?
Economic modeling, cost-effectiveness analysis, statistical analysis, study design, data management, literature reviews, and effective communication with stakeholders.
How does HEOR influence healthcare decisions?
HEOR provides evidence on value and cost-effectiveness that informs pricing, reimbursement, and market access decisions for therapies and interventions.